Fetching…
Fetching…
France · Europe
“The first supervised autonomous robot for dental veneer preparation.”
Montpellier-based medical robotics startup that developed the world's first supervised autonomous dental robot for porcelain laminate veneer preparation. The system grinds enamel to 0.06 mm mean accuracy while a dentist monitors remotely. Regulatory approval in India and the UK. First-in-human cases completed at Bharati Hospital, Pune, India. Raised €15 million Series A in August 2026 to scale deployment across the UK, Europe, and the United States.
Lupin Dental is a Montpellier-based medical robotics startup founded in 2020 that developed the world's first supervised autonomous dental robot, capable of performing tooth preparation procedures under professional oversight. The company raised a €15 million Series A round in August 2026 led by Fynveur, funding commercial scale-up and regulatory clearance activities.
The Lupin Dental system is designed to perform the technically demanding and repetitive mechanical aspects of dental procedures, specifically tooth preparation for crowns and restorations, with greater precision and consistency than manual technique. A qualified dentist supervises and can intervene at any point, maintaining professional accountability while the robot handles the mechanical execution. This supervised autonomy model is intended to navigate regulatory requirements while delivering demonstrable clinical benefits.
The company is part of a broader movement applying surgical and procedural robotics to specialties beyond orthopaedics and laparoscopic surgery, where robotics has been established for longer. Dental robotics represents a large global market given the high volume of restorative procedures performed annually.
Lupin Dental is pursuing CE marking for the European market and will require UKCA marking for UK deployment following post-Brexit regulatory divergence. The UK dental market is significant, and the company has expressed interest in European expansion following French commercial launch. UK dental practices and hospital trusts interested in early adoption should monitor regulatory clearance progress and engage directly with the company for partnership discussions.
Lupin Dental is a pre-commercial or early commercial stage company as of 2026, and no secondhand market exists. Medical robotics systems of this type are also subject to stringent maintenance, calibration, and software certification requirements that make informal secondhand purchase inadvisable. Any acquisition should go through the manufacturer to ensure compliance with medical device regulations and to maintain software certification status.